Literature DB >> 22135645

Prescribing practices for malaria in a rural Ugandan hospital: evaluation of a new malaria treatment policy.

P S Ucakacon1, J Achan, P Kutyabami, A R Odoi, N J Kalyango.   

Abstract

BACKGROUND: Increasing resistance to first line antimalarial drugs led to a change in the antimalarial policy of Uganda in 2005. Successful implementation of this policy depends on changing prescribing patterns of health workers.
OBJECTIVES: To describe prescribing patterns for malaria and associated factors in a rural Ugandan hospital following a change in antimalarial treatment policy from chloroquine plus sulphadoxine-pyrimethamine to artemisinin-based combination therapies.
METHODS: From the outpatients register, 715 prescriptions for malaria were reviewed. Data was collected on patient demographics, prescriber factors and prescription patterns. Prescriptions were considered to conform to the new antimalarial policy if artemether-lumefantrine was prescribed for uncomplicated malaria or quinine for treatment failure or complicated malaria.
RESULTS: The most frequently prescribed antimalarials for uncomplicated and complicated malaria were artemetherlumefantrine (n=564, 88.5%) and quinine (n=66, 84.6%) respectively. The proportion of prescriptions conforming to the new antimalarial treatment policy was 88.1% (n=630). Predictors of conformity were: duration in service of less than 6 years (OR=3.40. CI=1.24-9.33), prescriber's profession (OR=97.51, CI=27.29-348.34) and diagnosis of uncomplicated malaria (OR=10.13, CI=3.37-30.42).
CONCLUSIONS: Adequate training and provision of information relevant to the needs of different cadres of health workers is needed to promote effective uptake of new treatment policies.

Entities:  

Keywords:  Malaria policy; malaria treatment; prescribing practices

Mesh:

Year:  2011        PMID: 22135645      PMCID: PMC3220132          DOI: 10.4314/ahs.v11i3.70071

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  13 in total

1.  Averting a malaria disaster.

Authors:  N J White; F Nosten; S Looareesuwan; W M Watkins; K Marsh; R W Snow; G Kokwaro; J Ouma; T T Hien; M E Molyneux; T E Taylor; C I Newbold; T K Ruebush; M Danis; B M Greenwood; R M Anderson; P Olliaro
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

2.  Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.

Authors:  M R Kamya; N N Bakyaita; A O Talisuna; W M Were; S G Staedke
Journal:  Trop Med Int Health       Date:  2002-12       Impact factor: 2.622

Review 3.  The process of changing national malaria treatment policy: lessons from country-level studies.

Authors:  Holly Ann Williams; David Durrheim; Rima Shretta
Journal:  Health Policy Plan       Date:  2004-11       Impact factor: 3.344

Review 4.  Improving rational drug use in Africa: the example of Sudan.

Authors:  A I Awad; D E Ball; I B Eltayeb
Journal:  East Mediterr Health J       Date:  2007 Sep-Oct       Impact factor: 1.628

5.  Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

Authors:  Dejan Zurovac; Mickey Ndhlovu; Alexander K Rowe; Davidson H Hamer; Donald M Thea; Robert W Snow
Journal:  BMJ       Date:  2005-10-01

Review 6.  The public health impact of chloroquine resistance in Africa.

Authors:  J F Trape
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

7.  Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya.

Authors:  D Zurovac; A K Rowe; S A Ochola; A M Noor; B Midia; M English; R W Snow
Journal:  Int J Epidemiol       Date:  2004-07-15       Impact factor: 7.196

8.  Malaria case-management under artemether-lumefantrine treatment policy in Uganda.

Authors:  Dejan Zurovac; James K Tibenderana; Joan Nankabirwa; James Ssekitooleko; Julius N Njogu; John B Rwakimari; Sylvia Meek; Ambrose Talisuna; Robert W Snow
Journal:  Malar J       Date:  2008-09-19       Impact factor: 2.979

9.  Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

Authors:  Alexander N O Dodoo; Carole Fogg; Alex Asiimwe; Edmund T Nartey; Augustina Kodua; Ofori Tenkorang; David Ofori-Adjei
Journal:  Malar J       Date:  2009-01-05       Impact factor: 2.979

10.  Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study.

Authors:  Martin Meremikwu; Uduak Okomo; Chukwuemeka Nwachukwu; Angela Oyo-Ita; John Eke-Njoku; Joseph Okebe; Esu Oyo-Ita; Paul Garner
Journal:  Malar J       Date:  2007-05-04       Impact factor: 2.979

View more
  8 in total

1.  Health worker factors associated with prescribing of artemisinin combination therapy for uncomplicated malaria in rural Tanzania.

Authors:  Majige Selemani; Irene M Masanja; Dan Kajungu; Mbaraka Amuri; Mustafa Njozi; Rashid A Khatib; Salim Abdulla; Don de Savigny
Journal:  Malar J       Date:  2013-09-21       Impact factor: 2.979

2.  Utilization of Long-Lasting Insecticide Treated Nets and Parasitaemia at 6 Months after a Mass Distribution Exercise among Households in Mbarara Municipality, Uganda: A Cross-Sectional Community Based Study.

Authors:  Simpson Nuwamanya; Noel Kansiime; Emmanuel Aheebwe; Cecilia Akatukwasa; Harriet Nabulo; Eleanor Turyakira; Francis Bajunirwe
Journal:  Malar Res Treat       Date:  2018-08-01

3.  An Evaluation of Antibiotic Prescribing Practices in a Rural Refugee Settlement District in Uganda.

Authors:  Matua Bonniface; Winnie Nambatya; Kalidi Rajab
Journal:  Antibiotics (Basel)       Date:  2021-02-09

4.  Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics.

Authors:  Anthony K Mbonye; Josephine Birungi; Stephanie Yanow; Pascal Magnussen
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090

5.  Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda.

Authors:  David Sears; Ruth Kigozi; Arthur Mpimbaza; Stella Kakeeto; Asadu Sserwanga; Sarah G Staedke; Michelle Chang; Bryan K Kapella; Denis Rubahika; Moses R Kamya; Grant Dorsey
Journal:  Malar J       Date:  2013-07-19       Impact factor: 2.979

6.  Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.

Authors:  Asia Mohammed; Arnold Ndaro; Akili Kalinga; Alphaxard Manjurano; Jackline F Mosha; Dominick F Mosha; Marco van Zwetselaar; Jan B Koenderink; Frank W Mosha; Michael Alifrangis; Hugh Reyburn; Cally Roper; Reginald A Kavishe
Journal:  Malar J       Date:  2013-11-14       Impact factor: 2.979

7.  Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana.

Authors:  Kwame K Asare; Johnson N Boampong; Richmond Afoakwah; Elvis O Ameyaw; Rakesh Sehgal; Neils B Quashie
Journal:  Malar J       Date:  2014-06-26       Impact factor: 2.979

8.  Evaluation of anti-malarial drugs' use in Fitche Hospital, North Shoa, Oromia Region, Ethiopia.

Authors:  Rosa Getachew; Wote Amelo; Eshetu Mulisa Bobasa
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.